OBJECTIVE: Different cardioprotective strategies such as ischemic or pharmacologic preconditioning lead to attenuated ischemia/reperfusion (I/R) injury with less mechanical dysfunction and reduced infarct size on reperfusion. Improved mitochondrial function during ischemia as well as on reperfusion is a key feature of cardioprotection. The best reversible cardioprotective strategy is hypothermia. We investigated mitochondrial protection before, during, and after hypothermic ischemia by measuring mitochondrial (m)Ca2+, NADH, and reactive oxygen species (ROS) by online spectrophotofluorometry in intact hearts. METHODS: A fiberoptic cable was placed against the left ventricle of Langendorff-prepared guinea pig hearts to excite and record transmyocardial fluorescence at the appropriate wavelengths during 37 and 17 degrees C perfusion and during 30 min ischemia at 37 and 17 degrees C before 120 min reperfusion/rewarming. RESULTS: Cold perfusion caused significant reversible increases in m[Ca2+], NADH, and ROS. Hypothermia prevented a further increase in m[Ca2+], excess ROS formation and NADH oxidation/reduction imbalance during ischemia, led to a rapid return to preischemic values on warm reperfusion, and preserved cardiac function and tissue viability on reperfusion. CONCLUSIONS: Hypothermic perfusion at 17 degrees C caused moderate and reversible changes in mitochondrial function. However, hypothermia protects during ischemia, as shown by preservation of mitochondrial NADH energy balance and prevention of deleterious increases in m[Ca2+] and ROS formation. The close temporal relations of these factors during cooling and during ischemia suggest a causal link between mCa2+, mitochondrial energy balance, and ROS production.
OBJECTIVE: Different cardioprotective strategies such as ischemic or pharmacologic preconditioning lead to attenuated ischemia/reperfusion (I/R) injury with less mechanical dysfunction and reduced infarct size on reperfusion. Improved mitochondrial function during ischemia as well as on reperfusion is a key feature of cardioprotection. The best reversible cardioprotective strategy is hypothermia. We investigated mitochondrial protection before, during, and after hypothermic ischemia by measuring mitochondrial (m)Ca2+, NADH, and reactive oxygen species (ROS) by online spectrophotofluorometry in intact hearts. METHODS: A fiberoptic cable was placed against the left ventricle of Langendorff-prepared guinea pig hearts to excite and record transmyocardial fluorescence at the appropriate wavelengths during 37 and 17 degrees C perfusion and during 30 min ischemia at 37 and 17 degrees C before 120 min reperfusion/rewarming. RESULTS: Cold perfusion caused significant reversible increases in m[Ca2+], NADH, and ROS. Hypothermia prevented a further increase in m[Ca2+], excess ROS formation and NADH oxidation/reduction imbalance during ischemia, led to a rapid return to preischemic values on warm reperfusion, and preserved cardiac function and tissue viability on reperfusion. CONCLUSIONS: Hypothermic perfusion at 17 degrees C caused moderate and reversible changes in mitochondrial function. However, hypothermia protects during ischemia, as shown by preservation of mitochondrial NADH energy balance and prevention of deleterious increases in m[Ca2+] and ROS formation. The close temporal relations of these factors during cooling and during ischemia suggest a causal link between mCa2+, mitochondrial energy balance, and ROS production.
Authors: Mohammed Aldakkak; David F Stowe; James S Heisner; Matthias L Riess; Amadou K S Camara Journal: J Cardiovasc Pharmacol Ther Date: 2011-01-31 Impact factor: 2.457
Authors: Caitlin E O'Brien; Polan T Santos; Ewa Kulikowicz; Michael Reyes; Raymond C Koehler; Lee J Martin; Jennifer K Lee Journal: Dev Neurosci Date: 2019-05-20 Impact factor: 2.984
Authors: Renaud Tissier; Mourad Chenoune; Bijan Ghaleh; Michael V Cohen; James M Downey; Alain Berdeaux Journal: Cardiovasc Res Date: 2010-07-08 Impact factor: 10.787
Authors: Mahsa Ranji; Mohammad Masoudi Motlagh; Fahimeh Salehpour; Reyhaneh Sepehr; James S Heisner; Ranjan K Dash; Amadou K S Camara Journal: IEEE J Transl Eng Health Med Date: 2016-06-15 Impact factor: 3.316
Authors: Shigang Qiao; Jessica M Olson; Mark Paterson; Yasheng Yan; Ivan Zaja; Yanan Liu; Matthias L Riess; Judy R Kersten; Mingyu Liang; David C Warltier; Zeljko J Bosnjak; Zhi-Dong Ge Journal: Anesthesiology Date: 2015-10 Impact factor: 7.892